£80.67

Springer Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Price data last checked 55 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£81 today · previous high £81 · all-time low £81

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 36 days · 36 data points (no recent data)

Historical
Generating forecast…
£80.67 £80.64 £80.64 £80.65 £80.66 £80.67 £80.67 08 July 2026 16 July 2026 25 July 2026 03 August 2026 12 August 2026

Price Distribution

Price distribution over 36 days • 1 price levels

Days at Price
36 days 0 9 18 27 36 £81 Days at Price

Price Analysis

Most common price: £81 (36 days, 100.0%)

Price range: £81 - £81

Price levels: 1 different prices over 36 days

Description

The specific topic, “Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants – New Perspectives In Parkinson`S Disease Therapy,” was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson`s disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): ß-carbolines (BCs) and tetrahydroisoquinolines (TIQs). These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances. In this book we are going to summarize, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility oftheir therapeutic applications in neurodegenerative diseases such as Parkinson's disease.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2014
Listed Since
27 March 2014

Barcode

No barcode data available

Similar Products You Might Like

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)
98% match

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Springer

£103.27 25 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
95% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£165.06 03 Sep 2026
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
95% match

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Humana

£141.86 02 Oct 2026
Tryptophan Metabolism: Implications for Biological Processes, Health and Disease (Molecular and Integrative Toxicology)
95% match

Tryptophan Metabolism: Implications for Biological Processes, Health and Disease (Molecular and Integrative Toxicology)

Humana

£114.71 04 Oct 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
95% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Elsevier

£105.39 12 Sep 2026
Neurobiology of DOPA as a Neurotransmitter
95% match

Neurobiology of DOPA as a Neurotransmitter

CRC Press

£260.00 27 Aug 2026
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
95% match

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Humana

£136.54 24 Sep 2026
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
95% match

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Humana

£161.28 05 Oct 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
95% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£141.67 24 Sep 2026
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
95% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Elsevier

£82.62 26 Sep 2026
Milestones in Neurotoxicity and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu
95% match

Milestones in Neurotoxicity and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu

Elsevier

£60.53 22 Jul 2026
Serotonin: Cell Biology to Pharmacology and Therapeutics
95% match

Serotonin: Cell Biology to Pharmacology and Therapeutics

Springer

£237.21 23 Jul 2026
Serotonin: From Cell Biology to Pharmacology and Therapeutics
95% match

Serotonin: From Cell Biology to Pharmacology and Therapeutics

Springer

£236.59 12 Sep 2026
Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76
95% match

Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76

Elsevier

£155.00 25 Sep 2026
G Protein Methods and Protocols: Role of G Proteins in Psychiatric and Neurological Disorders: 31 (Neuromethods)
95% match

G Protein Methods and Protocols: Role of G Proteins in Psychiatric and Neurological Disorders: 31 (Neuromethods)

Humana

£122.22 05 Oct 2026
Advances in Neuropharmacology: Drugs and Therapeutics
95% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£77.00 26 Sep 2026
Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)
94% match

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Springer

£82.93 24 Sep 2026
Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks
94% match

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

£186.89 04 Sep 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
94% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Elsevier

£129.00 01 Oct 2026
Alpha01 L-Tyrosine 500mg with BioPerine - 120 Vegan Capsules
94% match

Alpha01 L-Tyrosine 500mg with BioPerine - 120 Vegan Capsules

ALPHA01

£6.79 17 Sep 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
94% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£128.31 27 Aug 2026
Nutrivo L-Tyrosine 1100mg - 120 Vegan Capsules, 2 Month Supply
94% match

Nutrivo L-Tyrosine 1100mg - 120 Vegan Capsules, 2 Month Supply

Nutrivo

£8.99 29 Jul 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
94% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Elsevier

£104.49 01 Oct 2026
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
94% match

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Springer

£160.91 11 Sep 2026